Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001–2011

A case series and literature review

Shoji Suzuki, Eriko Morino, Makoto Ishii, Ho Namkoong, Kazuma Yagi, Takanori Asakura, Takahiro Asami, Hiroshi Fujiwara, Yoshifumi Uwamino, Tomoyasu Nishimura, Sadatomo Tasaka, Tomoko Betsuyaku, Jin Takasaki, Satoshi Iwata, Naoki Hasegawa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Mycobacterium scrofulaceum is a well-known pathogen associated with cervical lymphadenitis in children. However, pulmonary M. scrofulaceum disease is a rare condition with unknown clinical features. The present study aimed to clarify the clinical features of pulmonary M. scrofulaceum disease described in recent cases and reports. Methods We reviewed the medical records of all adult patients with pulmonary M. scrofulaceum disease at Keio University Hospital and the National Center for Global Health and Medicine Center Hospital between 2001 and 2011. We also conducted a review of the PubMed database to identify additional cases of pulmonary M. scrofulaceum disease in adults. Results Our study identified 8 cases of pulmonary M. scrofulaceum disease at the 2 identified institutions during our study period. Most cases were diagnosed in middle-aged and elderly men with underlying pulmonary diseases such as chronic obstructive pulmonary disease and Mycobacterium avium complex lung disease, as well as those with a history of pulmonary tuberculosis. In contrast, most previously reported cases identified through our literature review had a history of dust inhalation or underlying silicosis. Three of 8 cases at our institutions and 20 of 23 cases from the literature were treated with combination therapies. Conclusions We conclude that in the recent histories of our institutions, pulmonary M. scrofulaceum disease has mainly occurred in patients with chronic pulmonary diseases. We further conclude that combination therapies that include clarithromycin might yield better patient outcomes.

Original languageEnglish
Pages (from-to)611-616
Number of pages6
JournalJournal of Infection and Chemotherapy
Volume22
Issue number9
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Mycobacterium scrofulaceum
Lung
Lung Diseases
Hospital Medicine
Mycobacterium avium Complex
Silicosis
Lymphadenitis
Clarithromycin
Dust
Pulmonary Tuberculosis
PubMed
Chronic Obstructive Pulmonary Disease
Inhalation
Medical Records
Chronic Disease
Databases

Keywords

  • Case series
  • Literature review
  • Nontuberculous mycobacteria
  • Pulmonary Mycobacterial scrofulaceum disease

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001–2011 : A case series and literature review. / Suzuki, Shoji; Morino, Eriko; Ishii, Makoto; Namkoong, Ho; Yagi, Kazuma; Asakura, Takanori; Asami, Takahiro; Fujiwara, Hiroshi; Uwamino, Yoshifumi; Nishimura, Tomoyasu; Tasaka, Sadatomo; Betsuyaku, Tomoko; Takasaki, Jin; Iwata, Satoshi; Hasegawa, Naoki.

In: Journal of Infection and Chemotherapy, Vol. 22, No. 9, 01.09.2016, p. 611-616.

Research output: Contribution to journalArticle

Suzuki, Shoji ; Morino, Eriko ; Ishii, Makoto ; Namkoong, Ho ; Yagi, Kazuma ; Asakura, Takanori ; Asami, Takahiro ; Fujiwara, Hiroshi ; Uwamino, Yoshifumi ; Nishimura, Tomoyasu ; Tasaka, Sadatomo ; Betsuyaku, Tomoko ; Takasaki, Jin ; Iwata, Satoshi ; Hasegawa, Naoki. / Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001–2011 : A case series and literature review. In: Journal of Infection and Chemotherapy. 2016 ; Vol. 22, No. 9. pp. 611-616.
@article{6e5bc847f29643d38d1f51ef6eb7150c,
title = "Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001–2011: A case series and literature review",
abstract = "Background Mycobacterium scrofulaceum is a well-known pathogen associated with cervical lymphadenitis in children. However, pulmonary M. scrofulaceum disease is a rare condition with unknown clinical features. The present study aimed to clarify the clinical features of pulmonary M. scrofulaceum disease described in recent cases and reports. Methods We reviewed the medical records of all adult patients with pulmonary M. scrofulaceum disease at Keio University Hospital and the National Center for Global Health and Medicine Center Hospital between 2001 and 2011. We also conducted a review of the PubMed database to identify additional cases of pulmonary M. scrofulaceum disease in adults. Results Our study identified 8 cases of pulmonary M. scrofulaceum disease at the 2 identified institutions during our study period. Most cases were diagnosed in middle-aged and elderly men with underlying pulmonary diseases such as chronic obstructive pulmonary disease and Mycobacterium avium complex lung disease, as well as those with a history of pulmonary tuberculosis. In contrast, most previously reported cases identified through our literature review had a history of dust inhalation or underlying silicosis. Three of 8 cases at our institutions and 20 of 23 cases from the literature were treated with combination therapies. Conclusions We conclude that in the recent histories of our institutions, pulmonary M. scrofulaceum disease has mainly occurred in patients with chronic pulmonary diseases. We further conclude that combination therapies that include clarithromycin might yield better patient outcomes.",
keywords = "Case series, Literature review, Nontuberculous mycobacteria, Pulmonary Mycobacterial scrofulaceum disease",
author = "Shoji Suzuki and Eriko Morino and Makoto Ishii and Ho Namkoong and Kazuma Yagi and Takanori Asakura and Takahiro Asami and Hiroshi Fujiwara and Yoshifumi Uwamino and Tomoyasu Nishimura and Sadatomo Tasaka and Tomoko Betsuyaku and Jin Takasaki and Satoshi Iwata and Naoki Hasegawa",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.jiac.2016.06.006",
language = "English",
volume = "22",
pages = "611--616",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "9",

}

TY - JOUR

T1 - Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001–2011

T2 - A case series and literature review

AU - Suzuki, Shoji

AU - Morino, Eriko

AU - Ishii, Makoto

AU - Namkoong, Ho

AU - Yagi, Kazuma

AU - Asakura, Takanori

AU - Asami, Takahiro

AU - Fujiwara, Hiroshi

AU - Uwamino, Yoshifumi

AU - Nishimura, Tomoyasu

AU - Tasaka, Sadatomo

AU - Betsuyaku, Tomoko

AU - Takasaki, Jin

AU - Iwata, Satoshi

AU - Hasegawa, Naoki

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background Mycobacterium scrofulaceum is a well-known pathogen associated with cervical lymphadenitis in children. However, pulmonary M. scrofulaceum disease is a rare condition with unknown clinical features. The present study aimed to clarify the clinical features of pulmonary M. scrofulaceum disease described in recent cases and reports. Methods We reviewed the medical records of all adult patients with pulmonary M. scrofulaceum disease at Keio University Hospital and the National Center for Global Health and Medicine Center Hospital between 2001 and 2011. We also conducted a review of the PubMed database to identify additional cases of pulmonary M. scrofulaceum disease in adults. Results Our study identified 8 cases of pulmonary M. scrofulaceum disease at the 2 identified institutions during our study period. Most cases were diagnosed in middle-aged and elderly men with underlying pulmonary diseases such as chronic obstructive pulmonary disease and Mycobacterium avium complex lung disease, as well as those with a history of pulmonary tuberculosis. In contrast, most previously reported cases identified through our literature review had a history of dust inhalation or underlying silicosis. Three of 8 cases at our institutions and 20 of 23 cases from the literature were treated with combination therapies. Conclusions We conclude that in the recent histories of our institutions, pulmonary M. scrofulaceum disease has mainly occurred in patients with chronic pulmonary diseases. We further conclude that combination therapies that include clarithromycin might yield better patient outcomes.

AB - Background Mycobacterium scrofulaceum is a well-known pathogen associated with cervical lymphadenitis in children. However, pulmonary M. scrofulaceum disease is a rare condition with unknown clinical features. The present study aimed to clarify the clinical features of pulmonary M. scrofulaceum disease described in recent cases and reports. Methods We reviewed the medical records of all adult patients with pulmonary M. scrofulaceum disease at Keio University Hospital and the National Center for Global Health and Medicine Center Hospital between 2001 and 2011. We also conducted a review of the PubMed database to identify additional cases of pulmonary M. scrofulaceum disease in adults. Results Our study identified 8 cases of pulmonary M. scrofulaceum disease at the 2 identified institutions during our study period. Most cases were diagnosed in middle-aged and elderly men with underlying pulmonary diseases such as chronic obstructive pulmonary disease and Mycobacterium avium complex lung disease, as well as those with a history of pulmonary tuberculosis. In contrast, most previously reported cases identified through our literature review had a history of dust inhalation or underlying silicosis. Three of 8 cases at our institutions and 20 of 23 cases from the literature were treated with combination therapies. Conclusions We conclude that in the recent histories of our institutions, pulmonary M. scrofulaceum disease has mainly occurred in patients with chronic pulmonary diseases. We further conclude that combination therapies that include clarithromycin might yield better patient outcomes.

KW - Case series

KW - Literature review

KW - Nontuberculous mycobacteria

KW - Pulmonary Mycobacterial scrofulaceum disease

UR - http://www.scopus.com/inward/record.url?scp=84992646648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992646648&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2016.06.006

DO - 10.1016/j.jiac.2016.06.006

M3 - Article

VL - 22

SP - 611

EP - 616

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 9

ER -